Shelly Aguilar
Psychiatric/Mental Health · Santa Ana, CANPI 1093239436
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 225 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$1K
- Alkermes, Inc.$829
- Indivior Inc.$632
- Otsuka America Pharmaceutical, Inc.$518
- AbbVie$363
- plus $532 from 7 others
What the payments were for
- Food & beverage$4,94599%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 53 | $1,135 |
| Neurocrine Biosciences, Inc. | 35 | $1,010 |
| Alkermes, Inc. | 39 | $829 |
| Indivior Inc. | 29 | $632 |
| Otsuka America Pharmaceutical, Inc. | 29 | $518 |
| AbbVie | 15 | $363 |
| Teva Pharmaceuticals USA, Inc. | 13 | $265 |
| E.r. Squibb & Sons, L.L.C. | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Sunovion Pharmaceuticals Inc. | 2 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
How this compares
$5,020 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Haloperidol | 11 | $419 |
| Benztropine Mesylate | 22 | $215 |
| Risperidone | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Santa Ana
- Janet SmithSanta Ana$18K
- Daniel MaiSanta Ana$13K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.